A Circulating miRNA-Based Scoring System Established by WGCNA to Predict Colon Cancer

Figure 3

External validation. (a) Colon cancer patients have higher hsa-miR-23a-3p levels in GSE112264. (b) Colon cancer patients have higher hsa-miR-663a levels in GSE112264. (c) ROC of a scoring system in GSE112264. (d) Colon cancer patients have higher hsa-miR-23a-3p levels in GSE106817. (e) Colon cancer patients have higher hsa-miR-663a levels in GSE106817. (f) ROC of a scoring system in GSE106817.

(a)

(b)

(c)

(d)

(e)

(f)